跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kynurenine
首页
药物
Kynurenine
Experimental
Small Molecule
Kynurenine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
10
H
12
N
2
O
3
CAS 编号
2922-83-0
UNII ID
02JW4J5R44
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
ANTIBODY AGAINST KYNURENINE
EP 4511404 A1
申请人: SALION GMBH
优先权: 2022
CN
EP
US
WO
7 件公开
ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY
EP 3492094 A1
申请人: UNIV TEXAS
优先权: 2013
CN
EP
US
7 件公开
US 9975959 B2
申请人: UNIV TEXAS
优先权: 2015
US
2 件公开
Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
EP 2664615 A1
申请人: NEURIM PHARMA 1991
优先权: 2006
EP
US
7 件公开
IMMUNOTHERAPY METHODS AND COMPOSITIONS INVOLVING TRYPTOPHAN METABOLIC PATHWAY MODULATORS
EP 3525803 A2
申请人: JUNO THERAPEUTICS INC
优先权: 2016
CN
EP
US
WO
6 件公开
HUMAN KYNURENINASE ENZYMES AND USES THEREOF
EP 3781179 A4
申请人: UNIV TEXAS
优先权: 2018
CN
EP
US
WO
6 件公开
PEGYLATED KYNURENINASE ENZYMES AND USES THEREOF FOR THE TREATMENT OF CANCER
EP 4045067 A1
申请人: IKENA ONCOLOGY INC
优先权: 2019
CN
EP
US
WO
5 件公开
A COMBINATION OF KYNURENINE AND ANTIGEN PRESENTING CELLS (APC) AS THERAPEUTICS AND METHODS FOR THEIR USE IN IMMUNE MODULATION
EP 3197466 B1
申请人: UNIV BRITISH COLUMBIA
优先权: 2014
EP
US
WO
5 件公开
Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes
US 2006142358 A1
申请人: AUTIER VALERIE
优先权: 2003
US
WO
5 件公开
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US 9260422 B2
申请人: DOMINGUEZ CELIA
优先权: 2012
CN
US
4 件公开
US 8536186 B2
申请人: WITYAK JOHN
优先权: 2009
US
4 件公开
US 8691824 B2
申请人: WITYAK JOHN
优先权: 2009
US
2 件公开
US 8883785 B2
申请人: DOMINGUEZ CELIA
优先权: 2011
US
2 件公开
US 2011230428 A1
申请人: WITYAK JOHN
优先权: 2008
US
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
US 9822058 B2
申请人: CHDI FOUNDATION INC
优先权: 2013
CN
US
4 件公开
US 9428464 B2
申请人: COURTNEY STEPHEN MARTIN
优先权: 2012
CN
US
3 件公开
US 9981918 B2
申请人: TOLEDO SHERMAN LETICIA M
优先权: 2012
CN
US
2 件公开
US 9884853 B2
申请人: CHDI FOUNDATION INC
优先权: 2014
US
2 件公开
US 9938252 B2
申请人: CHDI FOUNDATION INC
优先权: 2014
US
2 件公开
第 1 / 9 页
上一页
下一页
药物
反馈